Transcatheter Tricuspid Valve Replacement With the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in Severe Tricuspid Regurgitation

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1186 participants.

Also called NCT07321899

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 1,186 participants (planned count) (from the registry)
Sponsor
  • Medtronic Registry lists this organization as the lead sponsor
Registry
  • NCT NCT07321899
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07321899. Randomized; single masking; primary purpose treatment. Start 2026-09-11 (actual); primary completion 2031-09 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Transcatheter Tricuspid Valve Replacement With the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in Severe Tricuspid Regurgitation
Acronym
PATHFINDER
Condition
Severe Tricuspid Regurgitation
Intervention (Device)
Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System
Intervention (Device)
Edwards EVOQUE Tricuspid Valve Replacement (TTVR) System
Lead sponsor
Medtronic Cardiovascular (class: industry)

Record details

Record id
cardio:ct-nct07321899
Content hash
7963696fd9411025f53767408c1e151b602a5c19a239a3976737092c3333f9a5